Synonyms: | |
Status: | Approved (1970) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | N01AX03 |
UNII: | 690G0D6V8H |
InChI Key | YQEZLKZALYSWHR-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C13H16ClNO |
Molecular Weight | 237.73 |
AlogP | 2.9 |
Hydrogen Bond Acceptor | 2.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 2.0 |
Polar Surface Area | 29.1 |
Molecular species | NEUTRAL |
Aromatic Rings | 1.0 |
Heavy Atoms | 16.0 |
Primary Target | |
---|---|
GluN2C |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Ion channel
Ligand-gated ion channel
Ionotropic glutamate receptor
NMDA receptor
|
- | 610-10000 | - | 180-180 | - | |
Ion channel
Ligand-gated ion channel
Nicotinic acetylcholine receptor
Nicotinic acetylcholine receptor alpha subunit
|
- | 4950-11100 | - | - | 0 | |
Ion channel
Voltage-gated ion channel
Potassium channels
Two-pore domain potassium channel
|
- | - | - | - | 7 | |
Ion channel
Voltage-gated ion channel
Voltage-gated calcium channel
|
- | 1800 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Wounds and Injuries | 3 | D014947 | ClinicalTrials |
Pain | 3 | D010146 | ClinicalTrials |
Postoperative Complications | 3 | D011183 | ClinicalTrials |
Neoplasms | 3 | D009369 | ClinicalTrials |
Obesity, Morbid | 3 | D009767 | ClinicalTrials |
Suicidal Ideation | 3 | D059020 | ClinicalTrials |
Anemia, Sickle Cell | 3 | D000755 | ClinicalTrials |
Fractures, Bone | 3 | D050723 | ClinicalTrials |
Bipolar Disorder | 3 | D001714 | ClinicalTrials |
Neuralgia | 3 | D009437 | ClinicalTrials |
Depressive Disorder | 3 | D003866 | ClinicalTrials |
Alcoholism | 3 | D000437 | ClinicalTrials |
Shock, Septic | 3 | D012772 | ClinicalTrials |
Mucositis | 3 | D052016 | ClinicalTrials |
Headache | 3 | D006261 | ClinicalTrials |
Status Epilepticus | 3 | D013226 | ClinicalTrials |
Status Asthmaticus | 3 | D013224 | ClinicalTrials |
Delirium | 3 | D003693 | ClinicalTrials |
Renal Colic | 3 | D056844 | ClinicalTrials |
Chronic Pain | 3 | D059350 | ClinicalTrials |
Depression, Postpartum | 3 | D019052 | ClinicalTrials |
Depressive Disorder, Major | 3 | D003865 | ClinicalTrials |
Depressive Disorder | 3 | D003866 | ClinicalTrials |
Pharyngitis | 3 | D010612 | ClinicalTrials |
Rib Fractures | 3 | D012253 | ClinicalTrials |
Bronchial Spasm | 2 | D001986 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
Heart Septal Defects, Ventricular | 2 | D006345 | ClinicalTrials |
Epilepsy | 2 | D004827 | ClinicalTrials |
Coronavirus Infections | 2 | D018352 | ClinicalTrials |
Obsessive-Compulsive Disorder | 2 | D009771 | ClinicalTrials |
Temporomandibular Joint Disorders | 2 | D013705 | ClinicalTrials |
Fractures, Multiple | 2 | D000069076 | ClinicalTrials |
Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
Depressive Disorder, Treatment-Resistant | 2 | D061218 | ClinicalTrials |
Respiratory Distress Syndrome | 2 | D012128 | ClinicalTrials |
Complex Regional Pain Syndromes | 2 | D020918 | ClinicalTrials |
Subarachnoid Hemorrhage | 2 | D013345 | ClinicalTrials |
Child Development Disorders, Pervasive | 2 | D002659 | ClinicalTrials |
Paget Disease, Extramammary | 2 | D010145 | ClinicalTrials |
Ischemic Stroke | 2 | D000083242 | ClinicalTrials |
Borderline Personality Disorder | 2 | D001883 | ClinicalTrials |
Hypertrophy | 2 | D006984 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Lung Neoplasms | 2 | D008175 | ClinicalTrials |
Brain Injuries | 2 | D001930 | ClinicalTrials |
Strabismus | 2 | D013285 | ClinicalTrials |
Rett Syndrome | 2 | D015518 | ClinicalTrials |
Stress Disorders, Post-Traumatic | 2 | D013313 | ClinicalTrials |
Marijuana Abuse | 1 | D002189 | ClinicalTrials |
Schizophrenia | 1 | D012559 | ClinicalTrials |
Substance-Related Disorders | 1 | D019966 | ClinicalTrials |
Cognitive Dysfunction | 1 | D060825 | ClinicalTrials |
Sepsis | 1 | D018805 | ClinicalTrials |
Fatigue | 1 | D005221 | ClinicalTrials |
Tobacco Use Disorder | 1 | D014029 | ClinicalTrials |
Heart Arrest | 1 | D006323 | ClinicalTrials |
Mental Disorders | 1 | D001523 | ClinicalTrials |
Opioid-Related Disorders | 1 | D009293 | ClinicalTrials |
Perceptual Disorders | 1 | D010468 | ClinicalTrials |
Stroke | 1 | D020521 | ClinicalTrials |
Radius Fractures | 0 | D011885 | ClinicalTrials |
Phobia, Social | 0 | D000072861 | ClinicalTrials |
Hemorrhoids | 0 | D006484 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 6740-88-1 |
ChEBI | 6121 |
ChEMBL | CHEMBL742 |
DrugBank | DB01221 |
DrugCentral | 1523 |
EPA CompTox | DTXSID8023187 |
FDA SRS | 690G0D6V8H |
Human Metabolome Database | HMDB0015352 |
Guide to Pharmacology | 4233 |
KEGG | C07525 |
PharmGKB | PA450144 |
PubChem | 3821 |
SureChEMBL | SCHEMBL17084881 |